Representative Val T. Hoyle introduces H.R. 10444: Stop Corporate Takeovers of Physicians Act of 2026

We have received text from H.R. 10444: Stop Corporate Takeovers of Physicians Act of 2026. This bill was received on 2026-09-16, and currently has 10 cosponsors.

Here is a short summary of the bill:

This bill would create new federal rules limiting how outside corporations and management services organizations can control medical practices. In general, it would make it unlawful for a business entity that is not majority-owned and controlled by licensed clinicians to own or control a medical practice, employ or contract for the services of a licensed clinician, or practice medicine.

What counts as a “licensee” and a “medical practice”

The bill defines a licensee as a physician, physician assistant, nurse practitioner, or other advanced practice provider authorized by state law to diagnose and treat patients. A medical practice is a partnership or corporate entity formed to practice medicine.

Limits on corporate control

The bill would largely bar non-clinician-owned corporations from controlling medical practices. It also says that, to qualify as “majority-owned and controlled” by licensees, the clinicians must own at least half of the business and make up a majority of its governing body.

There are exceptions for:

• nonprofit or public health care providers,
• hospitals, hospital-affiliated clinics, critical access hospitals, and rural emergency hospitals.

Rules for employment agreements and workplace restrictions

The bill would prohibit non-compete clauses, non-disclosure agreements, and non-disparagement agreements involving licensees, health care providers, or management services organizations, with a narrow exception allowing some non-competes when the clinician owns at least 25% of the medical practice. It also states that certain confidentiality-related limits would not stop claims based on libel, slander, or other independent legal claims.

Protections for clinical judgment

Health care providers would be barred from using discipline, threats, retaliation, or other pressure to interfere with a clinician’s professional judgment or clinical decisions. The bill specifically says employers or other entities could not control things like:

• how much time a clinician spends with a patient,
• admission, observation, palliative care, or referral decisions,
• how quickly treatment is started,
• where patients are referred after discharge,
• diagnostic language or codes in medical records,
• what clinical orders are available in the medical record system.

Restrictions on management services organizations

The bill would impose detailed limits on management services organizations that provide non-medical business support to medical practices. These organizations would not be allowed to:

• control the sale or transfer of a medical practice’s ownership interests or assets,
• issue or arrange ownership interests in a medical practice,
• receive dividends from medical practice ownership interests,
• own or manage a medical practice,
• finance acquisition of ownership interests in a medical practice,
• enter into or change management contracts except under arm’s-length conditions with fair market value compensation,
• advertise a medical practice under another entity’s name,
• exercise de facto control over hiring, schedules, staffing, pay, clinical policies, billing, pricing, coding, or payor contracts in a way that affects care.

Any contract that allows prohibited control would be void and unenforceable.

Ownership requirements

Owners of a medical practice who are licensees would need to be licensed and present in the state where the practice serves patients, and they would need to be substantially involved in delivering medical care.

Enforcement

The Federal Trade Commission would enforce the law. Violations would be treated as unfair or deceptive acts or practices under federal trade law. The FTC would also get rulemaking authority to carry out the law. The bill would allow:

• private lawsuits by injured persons, with possible treble damages, attorney’s fees, and other relief,
• actions by state attorneys general on behalf of residents,
• court orders requiring violators to stop the conduct, divest entities if needed, and give up revenue received during the violation.

Federal health programs

The bill would add violations of these rules as a basis for exclusion or related action under the Social Security Act’s federal health program provisions.

Effective date

The new requirements would take effect one year after enactment.

Preemption

The bill would not override state laws that are at least as strict as the federal rules. States could keep stronger ownership, control, or clinician-protection laws.

Relevant Companies

None found

Representative Val T. Hoyle Bill Proposals

Here are some bills which have recently been proposed by Representative Val T. Hoyle:

• H.R.10444: Stop Corporate Takeovers of Physicians Act of 2026
• H.R.10094: Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
• H.R.9281: DASH Act
• H.R.8719: Shared Micromobility Investment Act
• H.R.8592: No WAR Act
• H.R.6864: SAW Act

You can track bills proposed by Representative Val T. Hoyle on Investivoq's politician page for Hoyle.

Representative Val T. Hoyle Net Worth

Investivoq estimates that Representative Val T. Hoyle is worth $1.0M, as of September 23rd, 2026. This is the 342nd highest net worth in Congress, per our live estimates.

Hoyle has approximately $0 invested in publicly traded assets which Investivoq is able to track live.

You can track Representative Val T. Hoyle's net worth on Investivoq's politician page for Hoyle.

Representative Val T. Hoyle Stock Trading

We have data on up to $6.2M of trades from Representative Val T. Hoyle, which we parsed from STOCK Act filings. Some of the largest trades include:

• A September 23rd, 2025 sale of up to $100K of $NVDA. The stock has risen 28.27% since then.
• A September 23rd, 2025 sale of up to $50K of $AVGO. The stock has risen 7.55% since then.
• A September 23rd, 2025 sale of up to $50K of $META. The stock has fallen 2.49% since then.
• A September 23rd, 2025 sale of up to $50K of $GOOGL. The stock has risen 39.54% since then.
• A September 23rd, 2025 sale of up to $50K of $MSFT. The stock has fallen 2.21% since then.

You can track Representative Val T. Hoyle's stock trading on Investivoq's politician page for Hoyle.

2026 Oregon's 4th Congressional District Election

There has been approximately $4,570,163 of spending in Oregon's 4th congressional district elections over the last two years, per our estimates.

Approximately $988,521 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:

• SAFER STRONGER OREGON PAC ($300,000)
• THINK BIG ($292,418)
• HMP ($281,623)
• A SAFER STRONGER OREGON PAC ($78,810)
• WORKING AMERICA ($35,230)

The rating for this race is currently "Solid D".

You can track this election on our matchup page for the 2026 Oregon's 4th congressional district election.

This article is not financial advice. See Investivoq's disclaimers for more information.